IMARX THERAPEUTICS COMPLETES $15 MILLION PRIVATE PLACEMENT

ImaRx Therapeutics, Inc., a biopharmaceutical company developing innovative solutions for stroke and vascular disease, today announced the closing of an equity financing, raising approximately $15 million in gross proceeds. The capital will be used for general corporate purposes, to fund product acquisitions, and to advance the clinical trials of the Company's lead products.

Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=1128335XSL_NEWSML_TO_NEWSML_WEB.xml)